This inventor holds 1 USPTO granted patent. Top assignee: Southern Research Institute. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jie Liu: Cancer-Therapy Patent Inventor
Introduction
Jie Liu is an inventor associated with Southern Research Institute and based in Vestavia Hills, Alabama. His patent work concerns potential cancer treatments using sulfur-based nucleotide and nucleoside compounds.
Latest Patents
Liu is credited with 1 patent: “Thiarabine- and thiarabine prodrug-based treatments.” The disclosure describes combination therapies involving sulfur-based nucleotide and nucleoside compounds for a range of cancers, including sarcomas, carcinomas, hematological cancers, and solid tumors. It also identifies specific cancer types and blood disorders as potential areas of application. The patent abstract notes that it is intended as a search aid and is not meant to limit the invention.
Career Highlights
Liu’s listed patent connects his work with research into combination therapies and cancer treatment. The available information identifies Southern Research Institute as his organization but does not provide further details about his role or career history.
Collaborations
Omar Moukha-Chafiq and Mark J. Suto are identified as Liu’s coworkers. The supplied information does not specify their roles in the patent or the nature of their collaboration.
Conclusion
Jie Liu’s patent record highlights an invention focused on thiarabine- and thiarabine prodrug-based combination therapies for cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile